As of 2025-10-16, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -17.08 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 12.94 USD, the upside of Forte Biosciences Inc is -231.97%.
Based on its market price of 12.94 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 231.97%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.08 - -17.08 | -17.08 | -231.97% |
| P/E | (37.43) - (53.96) | (46.62) | -460.3% |
| DDM - Stable | (22.20) - (62.60) | (42.40) | -427.7% |
| DDM - Multi | (15.99) - (36.09) | (22.27) | -272.1% |
| Market Cap (mil) | 160.84 |
| Beta | 3.15 |
| Outstanding shares (mil) | 12.43 |
| Enterprise Value (mil) | 54.70 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.84% |
| Cost of Debt | 5.00% |
| WACC | 7.76% |